ArticleCureus2025
Intestinal Sarcoidosis: A Diagnostic Conundrum.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcoidosis is a systemic granulomatous disorder of unknown cause, most commonly affecting the lungs and intrathoracic lymph nodes. We present the case of a 51-year-old woman in whom intestinal sarcoidosis was incidentally discovered alongside pulmonary involvement. The diagnosis was made during evaluation of trauma-related findings and confirmed through PET-CT, colonoscopy, and biopsy. GI sarcoidosis can closely mimic other granulomatous diseases, such as Crohn's disease or certain infections, making diagnosis particularly challenging. In this case, the presence of mediastinal lymphadenopathy with granulomas and PET-positive uptake in the ascending colon and a lymph node supported the diagnosis. Infectious and inflammatory bowel disease causes were excluded. The patient remained asymptomatic, so treatment was not initiated, consistent with current guidelines that recommend corticosteroids or surgical intervention only for symptomatic or severe disease. Intestinal sarcoidosis, particularly colonic involvement, remains exceedingly rare. However, clinicians should consider it in the differential diagnosis of colonic lesions, especially when imaging reveals evidence of extraintestinal sarcoidosis. Diagnosis relies on histopathological confirmation and the exclusion of other potential causes. Many patients remain asymptomatic and do not require treatment, although corticosteroids, immunomodulators, or surgery may be necessary in symptomatic or complicated cases. Further research is warranted to explore potential associations, such as with gastroesophageal reflux disease, and to determine optimal management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.